A Japanese nationwide multi-institutional retrospective survey of the treatments for neuroendocrine liver metastases (J-NELM study)

A Japanese nationwide multi-institutional retrospective survey of the treatments for neuroendocrine liver metastases (J-NELM study) - J-NELM study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060653

Enrollment

500

Registered

2026-02-12

Start date

2025-12-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuroendocrine liver metastasis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who received first-line therapy for neuroendocrine liver metastatsis between Jan 1 2012 through March 31 2025.

Exclusion criteria

Exclusion criteria: Patients who decline the registration of data.

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Recurrence/progresion-free survival, Prognotic factors	—

Countries

Japan

Contacts

Public ContactTaku Aoki

Dokkyo Medical University Hospital Department of Heapto-Biliary-Pancreatic Surgery

aoki-2su@dokkyomed.ac.jp0282861111

Outcome results